Last updated: March 25, 2025
Sponsor: University of Oslo
Overall Status: Active - Recruiting
Phase
N/A
Condition
Bone Marrow Transplant
Anemia
Treatment
N/AClinical Study ID
NCT06003660
282886
Ages 30-50 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
• patients receiving myeloablative conditioning for a first-time allo-HSCT and diagnosed with either a leukemia or a myelodysplastic syndrome
Exclusion
Exclusion Criteria:
disorders affecting the oral cavity including poor tooth-status
those using drugs affecting the gustatory/olfactory functions
those with brain disorders
those who have a chronic disorder affecting the immune system, have cancer or whoare pregnant.
Study Design
Total Participants: 70
Study Start date:
August 10, 2023
Estimated Completion Date:
June 30, 2026
Study Description
Connect with a study center
University of Oslo
Oslo, 0254
NorwayActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.